Efficacy and Safety of Low-Dose Apatinib Combined with Chemotherapy as Second-Line Treatment for Advanced Gastric Cancer: A Meta-Analysis.
用户EO9nReo4Hj6s
2个月前
101
10
已完结
1. 系统已在2025-05-04 14:56:27对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接:
其他信息:
L Wang, J Li, H Chen
Chemotherapy (0009-3157), 2024
search.ebscohost.com
Introduction: At present, there are several studies on low-dose apatinib combined with chemotherapy as a second-line treatment of advanced gastric cancer (AGC), but the …